Amarin

AMRN NASDAQ
15.15
+0.71
+4.92%
After Hours: 15.00 -0.15 -0.99% 19:59 08/16 EDT
Open
14.63
Prev Close
14.44
High
15.19
Low
14.51
Volume
7.24M
Avg Vol (3M)
8.88M
52 Week High
23.91
52 Week Low
2.650
% Turnover
2.18%
Market Cap
5.02B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Amarin AMRN stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
MORE >

Recently

Name
Price
%Change